Medical Disposables & Supplies Limited (JMSE: MDS)
Jamaica
· Delayed Price · Currency is JMD 1.700
0.00 (0.00%)
At close: Nov 22, 2024
MDS Income Statement
Financials in millions JMD. Fiscal year is April - March.
Millions JMD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Revenue | 3,797 | 3,709 | 3,770 | 3,416 | 2,423 | 2,481 | Upgrade
|
| Revenue Growth (YoY) | 1.55% | -1.60% | 10.34% | 41.01% | -2.35% | 11.67% | Upgrade
|
| Cost of Revenue | 3,099 | 2,995 | 2,756 | 2,480 | 1,824 | 1,922 | Upgrade
|
| Gross Profit | 698.44 | 713.9 | 1,014 | 936.46 | 598.89 | 558.93 | Upgrade
|
| Selling, General & Admin | 851.7 | 844.35 | 783.5 | 670.14 | 480.17 | 428.89 | Upgrade
|
| Other Operating Expenses | -16.72 | -15.99 | -10.1 | -9.27 | -5.22 | -5.65 | Upgrade
|
| Operating Expenses | 898.98 | 889.17 | 818 | 714.67 | 504.45 | 452.59 | Upgrade
|
| Operating Income | -200.55 | -175.27 | 195.72 | 221.8 | 94.45 | 106.34 | Upgrade
|
| Interest Expense | -160.39 | -159.93 | -104.17 | -71.65 | -70.09 | -48.14 | Upgrade
|
| Interest & Investment Income | 0.27 | 0.27 | 2.47 | 11.1 | 0.48 | 2.85 | Upgrade
|
| Currency Exchange Gain (Loss) | 31.03 | 14.4 | 2.87 | -17.97 | -11.04 | -19.48 | Upgrade
|
| EBT Excluding Unusual Items | -329.67 | -320.51 | 96.89 | 143.28 | 13.8 | 41.57 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | - | -7.59 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | -0.17 | 3.18 | 0.05 | 1.5 | Upgrade
|
| Other Unusual Items | - | - | - | - | 62.09 | - | Upgrade
|
| Pretax Income | -329.67 | -320.51 | 96.72 | 146.46 | 75.94 | 35.48 | Upgrade
|
| Income Tax Expense | -4.37 | -4.55 | 16.52 | 41.03 | 6.32 | 0.92 | Upgrade
|
| Earnings From Continuing Operations | -325.3 | -315.96 | 80.2 | 105.43 | 69.61 | 34.56 | Upgrade
|
| Minority Interest in Earnings | 33.22 | 23.87 | -8.06 | -8.47 | - | - | Upgrade
|
| Net Income | -292.08 | -292.09 | 72.14 | 96.97 | 69.61 | 34.56 | Upgrade
|
| Net Income to Common | -292.08 | -292.09 | 72.14 | 96.97 | 69.61 | 34.56 | Upgrade
|
| Net Income Growth | - | - | -25.61% | 39.29% | 101.45% | -69.35% | Upgrade
|
| Shares Outstanding (Basic) | 263 | 263 | 263 | 263 | 263 | 263 | Upgrade
|
| Shares Outstanding (Diluted) | 263 | 263 | 263 | 263 | 263 | 263 | Upgrade
|
| Shares Change (YoY) | 3.42% | - | - | - | - | - | Upgrade
|
| EPS (Basic) | -1.11 | -1.11 | 0.27 | 0.37 | 0.26 | 0.13 | Upgrade
|
| EPS (Diluted) | -1.11 | -1.11 | 0.27 | 0.37 | 0.26 | 0.13 | Upgrade
|
| EPS Growth | - | - | -25.61% | 39.29% | 101.45% | -69.35% | Upgrade
|
| Free Cash Flow | -121.42 | -91.83 | 10.98 | -161.6 | -20.46 | -110.46 | Upgrade
|
| Free Cash Flow Per Share | -0.46 | -0.35 | 0.04 | -0.61 | -0.08 | -0.42 | Upgrade
|
| Dividend Per Share | - | - | - | 0.090 | 0.070 | - | Upgrade
|
| Dividend Growth | - | - | - | 28.57% | - | - | Upgrade
|
| Gross Margin | 18.39% | 19.25% | 26.89% | 27.41% | 24.72% | 22.53% | Upgrade
|
| Operating Margin | -5.28% | -4.73% | 5.19% | 6.49% | 3.90% | 4.29% | Upgrade
|
| Profit Margin | -7.69% | -7.87% | 1.91% | 2.84% | 2.87% | 1.39% | Upgrade
|
| Free Cash Flow Margin | -3.20% | -2.48% | 0.29% | -4.73% | -0.84% | -4.45% | Upgrade
|
| EBITDA | -183.53 | -136.43 | 233.65 | 258.7 | 120.92 | 133.83 | Upgrade
|
| EBITDA Margin | -4.83% | -3.68% | 6.20% | 7.57% | 4.99% | 5.39% | Upgrade
|
| D&A For EBITDA | 17.02 | 38.84 | 37.93 | 36.9 | 26.48 | 27.49 | Upgrade
|
| EBIT | -200.55 | -175.27 | 195.72 | 221.8 | 94.45 | 106.34 | Upgrade
|
| EBIT Margin | -5.28% | -4.72% | 5.19% | 6.49% | 3.90% | 4.29% | Upgrade
|
| Effective Tax Rate | - | - | 17.08% | 28.01% | 8.33% | 2.60% | Upgrade
|
| Advertising Expenses | - | 77.39 | 58.18 | 43.12 | 28.32 | 16.81 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.